Inhibitor Therapeutics, Inc. Gain (Loss) Related to Litigation Settlement
Inhibitor Therapeutics, Inc. (INTI) reported Gain (Loss) Related to Litigation Settlement of $12.62 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2024-03-29
- Inhibitor Therapeutics, Inc. gain (loss) related to litigation settlement for fiscal 2022 was $12.62M.
| Period end | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|
| 2022-12-31 | $12.62M 10-K · filed 2024-03-29 |